Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-02-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-54117-6 |
| _version_ | 1797275220405387264 |
|---|---|
| author | S. F. Jørgensen M. E. Macpherson T. Bjørnetrø K. Holm M. Kummen A. Rashidi A. E. Michelsen T. Lekva B. Halvorsen M. Trøseid T. E. Mollnes R. K. Berge A. Yndestad T. Ueland T. H. Karlsen P. Aukrust J. R. Hov B. Fevang |
| author_facet | S. F. Jørgensen M. E. Macpherson T. Bjørnetrø K. Holm M. Kummen A. Rashidi A. E. Michelsen T. Lekva B. Halvorsen M. Trøseid T. E. Mollnes R. K. Berge A. Yndestad T. Ueland T. H. Karlsen P. Aukrust J. R. Hov B. Fevang |
| author_sort | S. F. Jørgensen |
| collection | DOAJ |
| first_indexed | 2024-03-07T15:10:15Z |
| format | Article |
| id | doaj.art-91f739ce296143479e08c8c2060570b4 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-03-07T15:10:15Z |
| publishDate | 2024-02-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-91f739ce296143479e08c8c2060570b42024-03-05T18:40:44ZengNature PortfolioScientific Reports2045-23222024-02-011411110.1038/s41598-024-54117-6Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiencyS. F. Jørgensen0M. E. Macpherson1T. Bjørnetrø2K. Holm3M. Kummen4A. Rashidi5A. E. Michelsen6T. Lekva7B. Halvorsen8M. Trøseid9T. E. Mollnes10R. K. Berge11A. Yndestad12T. Ueland13T. H. Karlsen14P. Aukrust15J. R. Hov16B. Fevang17Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Laboratory, Nordland Hospital, Bodø, and Faculty of Health Sciences, K.G. Jebsen TREC, University of TromsøDepartment of Clinical Science, University of BergenResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University HospitalResearch Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospitalhttps://doi.org/10.1038/s41598-024-54117-6 |
| spellingShingle | S. F. Jørgensen M. E. Macpherson T. Bjørnetrø K. Holm M. Kummen A. Rashidi A. E. Michelsen T. Lekva B. Halvorsen M. Trøseid T. E. Mollnes R. K. Berge A. Yndestad T. Ueland T. H. Karlsen P. Aukrust J. R. Hov B. Fevang Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency Scientific Reports |
| title | Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency |
| title_full | Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency |
| title_fullStr | Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency |
| title_full_unstemmed | Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency |
| title_short | Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency |
| title_sort | retraction note rifaximin alters gut microbiota profile but does not affect systemic inflammation a randomized controlled trial in common variable immunodeficiency |
| url | https://doi.org/10.1038/s41598-024-54117-6 |
| work_keys_str_mv | AT sfjørgensen retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT memacpherson retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT tbjørnetrø retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT kholm retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT mkummen retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT arashidi retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT aemichelsen retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT tlekva retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT bhalvorsen retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT mtrøseid retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT temollnes retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT rkberge retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT ayndestad retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT tueland retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT thkarlsen retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT paukrust retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT jrhov retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency AT bfevang retractionnoterifaximinaltersgutmicrobiotaprofilebutdoesnotaffectsystemicinflammationarandomizedcontrolledtrialincommonvariableimmunodeficiency |